BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 15879100)

  • 1. B cell receptor (BCR) cross-talk: CD40 engagement creates an alternate pathway for BCR signaling that activates I kappa B kinase/I kappa B alpha/NF-kappa B without the need for PI3K and phospholipase C gamma.
    Mizuno T; Rothstein TL
    J Immunol; 2005 May; 174(10):6062-70. PubMed ID: 15879100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B cell receptor cross-talk: exposure to lipopolysaccharide induces an alternate pathway for B cell receptor-induced ERK phosphorylation and NF-kappa B activation.
    Dye JR; Palvanov A; Guo B; Rothstein TL
    J Immunol; 2007 Jul; 179(1):229-35. PubMed ID: 17579042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B cell receptor (BCR) cross-talk: CD40 engagement enhances BCR-induced ERK activation.
    Mizuno T; Rothstein TL
    J Immunol; 2005 Mar; 174(6):3369-76. PubMed ID: 15749869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigen-receptor cross-linking and lipopolysaccharide trigger distinct phosphoinositide 3-kinase-dependent pathways to NF-kappa B activation in primary B cells.
    Bone H; Williams NA
    Int Immunol; 2001 Jun; 13(6):807-16. PubMed ID: 11369709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutting edge: CD40 engagement eliminates the need for Bruton's tyrosine kinase in B cell receptor signaling for NF-kappa B.
    Mizuno T; Rothstein TL
    J Immunol; 2003 Mar; 170(6):2806-10. PubMed ID: 12626529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphatidylinositol 3-kinase-dependent mitogen-activated protein/extracellular signal-regulated kinase kinase 1/2 and NF-kappa B signaling pathways are required for B cell antigen receptor-mediated cyclin D2 induction in mature B cells.
    Piatelli MJ; Wardle C; Blois J; Doughty C; Schram BR; Rothstein TL; Chiles TC
    J Immunol; 2004 Mar; 172(5):2753-62. PubMed ID: 14978074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Syk mediates BCR- and CD40-signaling integration during B cell activation.
    Ying H; Li Z; Yang L; Zhang J
    Immunobiology; 2011 May; 216(5):566-70. PubMed ID: 21074890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphatidylinositol 3-kinase and NF-kappa B/Rel are at the divergence of CD40-mediated proliferation and survival pathways.
    Andjelic S; Hsia C; Suzuki H; Kadowaki T; Koyasu S; Liou HC
    J Immunol; 2000 Oct; 165(7):3860-7. PubMed ID: 11034392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B cell receptor (BCR) cross-talk: IL-4 creates an alternate pathway for BCR-induced ERK activation that is phosphatidylinositol 3-kinase independent.
    Guo B; Rothstein TL
    J Immunol; 2005 May; 174(9):5375-81. PubMed ID: 15843535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD40 induces human multiple myeloma cell migration via phosphatidylinositol 3-kinase/AKT/NF-kappa B signaling.
    Tai YT; Podar K; Mitsiades N; Lin B; Mitsiades C; Gupta D; Akiyama M; Catley L; Hideshima T; Munshi NC; Treon SP; Anderson KC
    Blood; 2003 Apr; 101(7):2762-9. PubMed ID: 12433678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transient and selective NF-kappa B p65 serine 536 phosphorylation induced by T cell costimulation is mediated by I kappa B kinase beta and controls the kinetics of p65 nuclear import.
    Mattioli I; Sebald A; Bucher C; Charles RP; Nakano H; Doi T; Kracht M; Schmitz ML
    J Immunol; 2004 May; 172(10):6336-44. PubMed ID: 15128824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BCR targets cyclin D2 via Btk and the p85alpha subunit of PI3-K to induce cell cycle progression in primary mouse B cells.
    Glassford J; Soeiro I; Skarell SM; Banerji L; Holman M; Klaus GG; Kadowaki T; Koyasu S; Lam EW
    Oncogene; 2003 Apr; 22(15):2248-59. PubMed ID: 12700661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD40 activates NF-kappa B and c-Jun N-terminal kinase and enhances chemokine secretion on activated human hepatic stellate cells.
    Schwabe RF; Schnabl B; Kweon YO; Brenner DA
    J Immunol; 2001 Jun; 166(11):6812-9. PubMed ID: 11359840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The adaptor protein BLNK is required for b cell antigen receptor-induced activation of nuclear factor-kappa B and cell cycle entry and survival of B lymphocytes.
    Tan JE; Wong SC; Gan SK; Xu S; Lam KP
    J Biol Chem; 2001 Jun; 276(23):20055-63. PubMed ID: 11274146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B-1 cells are deficient in Lck: defective B cell receptor signal transduction in B-1 cells occurs in the absence of elevated Lck expression.
    Francés R; Tumang JR; Rothstein TL
    J Immunol; 2005 Jul; 175(1):27-31. PubMed ID: 15972627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD38 signaling regulates B lymphocyte activation via a phospholipase C (PLC)-gamma 2-independent, protein kinase C, phosphatidylcholine-PLC, and phospholipase D-dependent signaling cascade.
    Moreno-García ME; López-Bojórques LN; Zentella A; Humphries LA; Rawlings DJ; Santos-Argumedo L
    J Immunol; 2005 Mar; 174(5):2687-95. PubMed ID: 15728476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B and T lymphocyte attenuator regulates B cell receptor signaling by targeting Syk and BLNK.
    Vendel AC; Calemine-Fenaux J; Izrael-Tomasevic A; Chauhan V; Arnott D; Eaton DL
    J Immunol; 2009 Feb; 182(3):1509-17. PubMed ID: 19155498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B cell receptor-mediated Syk-independent activation of phosphatidylinositol 3-kinase, Ras, and mitogen-activated protein kinase pathways.
    Yokozeki T; Adler K; Lankar D; Bonnerot C
    J Immunol; 2003 Aug; 171(3):1328-35. PubMed ID: 12874222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD86 stimulation on a B cell activates the phosphatidylinositol 3-kinase/Akt and phospholipase C gamma 2/protein kinase C alpha beta signaling pathways.
    Kin NW; Sanders VM
    J Immunol; 2006 Jun; 176(11):6727-35. PubMed ID: 16709832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NF-kappaB overrides the apoptotic program of TNF receptor 1 but not CD40 in carcinoma cells.
    Davies CC; Bem D; Young LS; Eliopoulos AG
    Cell Signal; 2005 Jun; 17(6):729-38. PubMed ID: 15722197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.